Tumor therapy with targeted atomic nanogenerators. - Wikidata - wikimedia - TriplyDB

Tumor therapy with targeted atomic nanogenerators.

Tumor therapy with targeted atomic nanogenerators.

http://www.wikidata.org/entity/Q34102138

about

Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1 T cell receptor mimic antibodies for cancer therapy Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization Tumor immunotargeting using innovative radionuclides Radioimmunotherapy of human tumours Antibody-targeted radiation cancer therapy Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes Fibrillous carbon nanotube: an unexpected journey Deploying RNA and DNA with Functionalized Carbon Nanotubes Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice Cerenkov luminescence imaging of medical isotopes.Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells.A high-throughput screen for alpha particle radiation protectants.Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes.A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen.Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma.Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.An overview of targeted alpha therapy.Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues Radioimmunotherapy with α-particle-emitting radionuclides.Targeted alpha anticancer therapies: update and future prospects Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.The significance of immunohistochemistry in the diagnosis and therapy of neoplasms.Radioimmunotherapy for acute leukemia.The use of radioimmunoconjugates in stem cell transplantation.Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors.Will nanotechnology influence targeted cancer therapy?Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.Integrin targeted delivery of radiotherapeutics.Tumor targeting, trifunctional dendritic wedge.Cancer radioimmunotherapy.DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy.

P2860

Q24629826-059AF36D-6B75-43A5-BCEE-321613E673CE Q24673319-E0E5F611-E853-4567-88C9-30B24251C9E0 Q24685212-A1B6E282-A038-4949-9759-3C358C5D5E79 Q26768271-7744AF53-3E26-4396-9E0E-472807A6C0B9 Q27303072-D9F79BD3-2553-4098-8FA8-C44E34CD906E Q28083230-7F94E301-934E-427A-BF7E-C4B85DEFBB7F Q28088825-AED25D80-C51C-4080-BA43-E827CD1C2B82 Q28264580-8FD56162-9E38-4F98-B376-6775509A5614 Q28384090-4C9E4F25-B10E-4D89-9175-08FE097FC59A Q28391694-7C920048-4030-44A9-803C-A9B27FDB8998 Q28468241-18CED96C-C669-4EB4-80E7-0BEC0B948329 Q28469068-F366F5C8-C8DC-4FA3-A323-56AF9572F516 Q28469301-6063CFED-816C-4B5A-839D-9F9C1D617869 Q30499280-ED3270D5-7F0B-44A8-B4DB-6CF9BD23BC76 Q31048088-ACC0D8A0-57D6-42C2-8CBB-B0CFCC7634D4 Q33311571-E17A49A2-2C60-4108-9FE7-7E4F2DAD8B16 Q33455875-7917E012-C514-48C6-86A4-FB7D0F8F9A64 Q33640606-20124F80-FA1A-46D8-8D82-F69189D1B669 Q33762411-8C9B39C3-8362-46E8-A894-D0F119C3EBCC Q33763004-A638EBF9-DAD0-43CE-8063-16486CCE27B3 Q34077332-9F35F900-F7C9-4A96-A7E9-C984C1772693 Q34160678-E7C50748-6FE2-4977-8B00-47F545EEDF5D Q34238513-56931D29-2AD0-4FEB-A675-19D44B19F8D4 Q34268110-3690C1C2-CE77-4444-BE6E-F34FE3B8590F Q34324413-B1B88B59-379D-4B8D-8862-65E1187A2083 Q34389457-EF2F7494-F4F3-4DE9-9FF3-6EC1B0124A13 Q34395062-03AD1847-423A-434B-900C-D52EF84B3908 Q34419562-75620563-B010-425E-923D-1A59DB5A902D Q34511439-5CD8D671-A35E-4129-9257-FF064119A9C4 Q34555716-53DF03DB-6106-4706-B639-C2096AF787B7 Q34602545-AAA46F88-D391-49F8-8948-9827BBC34140 Q34608650-6F1C597A-957C-42FE-A2D0-DC3E29042151 Q34679582-33AD1835-9DA0-4B7C-B9E9-8F7A5E5901D2 Q34682223-8BE7A4DD-E508-4294-B714-E2E9BFC899A3 Q34706794-9F43ACC7-7C43-4536-B110-27B395BD3342 Q34762427-370463CF-6209-4A3D-8A47-BE9B7044CC25 Q34912696-29D97BE7-880A-4068-9A38-15674C7AFFC9 Q35013469-DB5A316D-B977-4D2C-82D9-ED6FD0686428 Q35070045-BB10A2BD-EB18-4441-B495-D9B9A44DDF74 Q35091643-78B829DD-03F6-48E2-8DCB-19210A66F42D

P2860

Tumor therapy with targeted atomic nanogenerators.

http://www.wikidata.org/entity/Q34102138

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Tumor therapy with targeted atomic nanogenerators.

@ast

Tumor therapy with targeted atomic nanogenerators.

@en

Tumor therapy with targeted atomic nanogenerators.

@nl

type

label

Tumor therapy with targeted atomic nanogenerators.

@ast

Tumor therapy with targeted atomic nanogenerators.

@en

Tumor therapy with targeted atomic nanogenerators.

@nl

prefLabel

Tumor therapy with targeted atomic nanogenerators.

@ast

Tumor therapy with targeted atomic nanogenerators.

@en

Tumor therapy with targeted atomic nanogenerators.

@nl

P1433

Q34102138-EB00A458-616F-4DFD-A267-BC071356F8F2

P1476

Q34102138-6CB535CA-4D31-4D0A-BF57-033384207FAB

P2093

Q34102138-078EE9B9-E561-413C-9E78-DF681629F282

Q34102138-1432B533-7554-4356-9D02-A94642E52EA5

Q34102138-31DE59D6-B4E0-4C5E-A041-38C7F760348A

Q34102138-3AB32F16-E8BD-4F00-BF7F-3AB9EF26D2E2

Q34102138-51418BA6-5E3E-4E36-ADAA-BEAAB8587067

Q34102138-669BF198-406A-41A9-8092-7D96B4ABF35E

Q34102138-85414642-FE39-4986-B400-915EA6B62B6A

Q34102138-8EFEF418-27F8-4FD7-A62A-DD7AAD27ED03

Q34102138-B4C9CDC3-E4DB-46FE-904E-7FA244C307E2

Q34102138-C43F912C-C02F-42AD-9574-F99537693E2B

P304

Q34102138-D031880E-7F69-4AD1-A8E0-E46E23D757BC

P31

Q34102138-3A900782-1C05-4DA5-A840-53F996C7D702

P356

Q34102138-EE986853-ACB3-4309-8DAA-A03B22CED907

P407

Q34102138-360F715A-9BD1-4B3E-933F-BF6F70448FC2

P433

Q34102138-A7D224C3-0AC1-462C-BE0F-2BEF2413C1BD

P478

Q34102138-E04C5F6B-73CC-4B5A-B323-5524F6C4A6A9

P577

Q34102138-FD95134E-7BCD-4CAF-98FF-2717D30D4F6F

P5875

Q34102138-3DE81C93-A79E-4A80-9B43-C8695BBD7B59

P698

Q34102138-A3A66AC8-D07D-4771-8D17-AB363A8A4774

P356

SCIENCE.1064126

P1433

P1476

Tumor therapy with targeted atomic nanogenerators.

@en

P2093

D A Scheinberg

http://www.w3.org/2001/XMLSchema#string

D Ma

http://www.w3.org/2001/XMLSchema#string

J Simon

http://www.w3.org/2001/XMLSchema#string

K Wu

http://www.w3.org/2001/XMLSchema#string

L T Lai

http://www.w3.org/2001/XMLSchema#string

M J Curcio

http://www.w3.org/2001/XMLSchema#string

M Miederer

http://www.w3.org/2001/XMLSchema#string

M R McDevitt

http://www.w3.org/2001/XMLSchema#string

N H Bander

http://www.w3.org/2001/XMLSchema#string

P Borchardt

http://www.w3.org/2001/XMLSchema#string

P304

1537-1540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1064126

http://www.w3.org/2001/XMLSchema#string

P407

P433

5546

http://www.w3.org/2001/XMLSchema#string

P478

294

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11642922

http://www.w3.org/2001/XMLSchema#string

P698

11711678

http://www.w3.org/2001/XMLSchema#string